Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

18.88
Delayed Data
As of 4:00pm ET
 -0.79 / -4.02%
Today’s Change
12.25
Today|||52-Week Range
33.74
+4.14%
Year-to-Date
No recent news for Depomed Inc.

Today’s Trading

Previous close19.67
Today’s open18.61
Day’s range18.09 - 19.31
Volume1,174,594
Average volume (3 months)1,893,893
Market cap$1.2B
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-161.46%
Earnings growth (this year)+71.80%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)-12.20%
P/E ratioNM
Price/Sales3.18
Price/Book3.77

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd-2.50-8.13%
OASMOasmia Pharmaceutica...-0.31-8.61%
VBLTVascular Biogenics L...-0.13-3.09%
NEPTNeptune Technologies...-0.03-2.91%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)$0.27
Annual revenue (last year)$342.7M
Annual profit (last year)-$75.7M
Net profit margin-22.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts

Partner Offers

Search for Jobs